Cargando…

End-Stage renal disease and 30-day mortality for adults with and without COVID-19

Detalles Bibliográficos
Autores principales:	Harrison, Stephanie L., Buckley, Benjamin J.R., Fazio-Eynullayeva, Elnara, Underhill, Paula, Lane, Deirdre A., Lip, Gregory Y.H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Federation of Internal Medicine. Published by Elsevier B.V. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649657/ https://www.ncbi.nlm.nih.gov/pubmed/33187792 http://dx.doi.org/10.1016/j.ejim.2020.11.003

Ejemplares similares

Atrial fibrillation and the risk of 30‐day incident thromboembolic events, and mortality in adults ≥ 50 years with COVID‐19
por: Harrison, Stephanie L., et al.
Publicado: (2020)

Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2021)

Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis
por: Harrison, Stephanie L., et al.
Publicado: (2020)

Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications
por: Harrison, Stephanie L., et al.
Publicado: (2021)

Exercise‐Based Cardiac Rehabilitation and All‐Cause Mortality Among Patients With Atrial Fibrillation
por: Buckley, Benjamin J. R., et al.
Publicado: (2021)

Association of Exercise-Based Cardiac Rehabilitation with Progression of Paroxysmal to Sustained Atrial Fibrillation
por: Buckley, Benjamin J. R., et al.
Publicado: (2021)

Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real‐World Data
por: Buckley, Benjamin J. R., et al.
Publicado: (2021)

Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2021)

Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
por: Ding, Wern Yew, et al.
Publicado: (2022)

Evolving Effect of the COVID-19 Pandemic on Cancer-Related Encounters
por: London, Jack W., et al.
Publicado: (2022)

207. Burden of Post-Transplant Neutropenia and Leukopenia among Kidney Transplant Recipients: A Multi-Institutional Real-World Observational Study
por: Raval, Amit D, et al.
Publicado: (2022)

Stroke and Bleeding Risk in Atrial Fibrillation
por: Senoo, Keitaro, et al.
Publicado: (2014)

Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF Trials
por: Proietti, Marco, et al.
Publicado: (2016)

Clinical Comparison of 30-Day Mortalities and 6-Month Functional Recoveries after Spontaneous Intracerebral Hemorrhage in Patients with or without End-Stage Renal Disease
por: Kim, Kang Rae, et al.
Publicado: (2013)

Cross-cultural adaptation into Punjabi of the English version of the Hospital Anxiety and Depression Scale
por: Lane, Deirdre A, et al.
Publicado: (2007)

Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis
por: Proietti, Riccardo, et al.
Publicado: (2023)

Reasons for admission and predictors of national 30-day readmission rates in patients with end-stage renal disease on peritoneal dialysis
por: Chan, Lili, et al.
Publicado: (2017)

The Liverpool Heart And bRain Project (L-HARP): Protocol for an Observational Cohort Study of Cardiovascular Risk and Outcomes Following Stroke
por: Harrison, Stephanie L, et al.
Publicado: (2022)

TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT)
por: Smith, Danielle E, et al.
Publicado: (2010)

Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies
por: Ding, Wern Yew, et al.
Publicado: (2020)

Anticoagulation Control and Major Adverse Clinical Events in Patients with Operated Valvular Heart Disease with and without Atrial Fibrillation Receiving Vitamin K Antagonists
por: Zulkifly, Hanis H., et al.
Publicado: (2023)

The impact of frailty on the management of atrial fibrillation
por: Harrison, Stephanie L., et al.
Publicado: (2023)

The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review
por: Stevens, David, et al.
Publicado: (2021)

Modelling of longitudinal data to predict cardiovascular disease risk: a methodological review
por: Stevens, David, et al.
Publicado: (2021)

C-reactive protein levels are associated with early cardiac complications or death in patients with acute ischemic stroke: a propensity-matched analysis of a global federated health from the TriNetX network
por: Bucci, Tommaso, et al.
Publicado: (2023)

Interactive Remote Patient Monitoring Devices for Managing Chronic Health Conditions: Systematic Review and Meta-analysis
por: Leo, Donato Giuseppe, et al.
Publicado: (2022)

Cardiac rehabilitation meta-analysis of trials in patients with coronary heart disease using individual participant data (CaReMATCH): Project protocol
por: Buckley, Benjamin J.R., et al.
Publicado: (2020)

Incident Heart Failure in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study
por: Khalid, Usman, et al.
Publicado: (2018)

Effectiveness and Safety of Antithrombotic Medication in Patients With Atrial Fibrillation and Intracranial Hemorrhage: Systematic Review and Meta-Analysis
por: Ivany, Elena, et al.
Publicado: (2022)

Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis
por: Proietti, Riccardo, et al.
Publicado: (2023)

30 Days Wild: Development and Evaluation of a Large-Scale Nature Engagement Campaign to Improve Well-Being
por: Richardson, Miles, et al.
Publicado: (2016)

Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal
por: Lane, Deirdre A, et al.
Publicado: (2020)

The Effect of Model for End-Stage Liver Disease 3.0 on Disparities between Patients with and without Hepatocellular Carcinoma in Korea
por: Kim, Kunhee, et al.
Publicado: (2023)

Clinical Features and Prognosis in Patients with Atrial Fibrillation and Prior Stroke: Comparing the Fushimi and Darlington AF Registries
por: Ogawa, Hisashi, et al.
Publicado: (2017)

Modification of the HeRO Graft Allowing Earlier Cannulation and Reduction in Catheter Dependent Days in Patients with End Stage Renal Disease: A Single Center Retrospective Review
por: Hart, Deirdre, et al.
Publicado: (2014)

Kanban In 30 days
por: Björkholm, Tomas
Publicado: (2015)

Nephrology in 30 days /
por: Reilly, Robert F., M.D
Publicado: (2005)

Day-to-Day Variation of Insulin Requirements of Patients With Type 2 Diabetes and End-Stage Renal Disease Undergoing Maintenance Hemodialysis
por: Sobngwi, Eugene, et al.
Publicado: (2010)

Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillation
por: Huppertz, Nina, et al.
Publicado: (2019)

Anticoagulation Control in Older Atrial Fibrillation Patients Receiving Vitamin K Antagonist Therapy for Stroke Prevention
por: Zulkifly, Hanis, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5es3avdjaci93alo6cnn619nms